16th Community Wide Experiment on the
Critical Assessment of Techniques for Protein Structure Prediction
Ligand Predictions Analysis
Results Home Table Browser
Target: 
Text
Models / Ligands Ligand scores
    #     Model     Group
    Name
     Target Ligand     LDDT_pli     RMSD     LDDT_lp     BB_RMSD
1. L3048LG420_5 Zou_aff2 ligand_L0R_B_1.mol 0.955 0.513 0.979 0.257
2. L3048LG204_3 Zou ligand_L0R_B_1.mol 0.890 1.604 0.976 0.265
3. L3048LG420_2 Zou_aff2 ligand_L0R_B_1.mol 0.890 1.604 0.976 0.265
4. L3048LG055_4 LCDD-team ligand_L0R_B_1.mol 0.887 0.940 0.922 0.518
5. L3048LG432_1 DIMAIO ligand_L0R_B_1.mol 0.875 1.612 0.952 0.332
6. L3048LG432_3 DIMAIO ligand_L0R_B_1.mol 0.869 1.621 0.938 0.470
7. L3048LG432_2 DIMAIO ligand_L0R_B_1.mol 0.868 1.636 0.975 0.221
8. L3048LG204_1 Zou ligand_L0R_B_1.mol 0.857 1.765 0.931 0.496
9. L3048LG420_1 Zou_aff2 ligand_L0R_B_1.mol 0.857 1.765 0.931 0.496
10. L3048LG207_1 MULTICOM_ligand ligand_L0R_B_1.mol 0.849 1.862 0.938 0.363
11. L3048LG408_5 SNU-CHEM-lig ligand_L0R_B_1.mol 0.834 2.070 0.943 0.425
12. L3048LG408_2 SNU-CHEM-lig ligand_L0R_B_1.mol 0.828 2.271 0.941 0.485
13. L3048LG055_3 LCDD-team ligand_L0R_B_1.mol 0.822 2.144 0.922 0.518
14. L3048LG408_3 SNU-CHEM-lig ligand_L0R_B_1.mol 0.816 2.097 0.944 0.295
15. L3048LG055_2 LCDD-team ligand_L0R_B_1.mol 0.812 2.332 0.922 0.518
16. L3048LG274_4 kozakovvajda ligand_L0R_B_1.mol 0.802 2.512 0.951 0.456
17. L3048LG494_4 ClusPro ligand_L0R_B_1.mol 0.802 2.512 0.951 0.456
18. L3048LG494_2 ClusPro ligand_L0R_B_1.mol 0.802 2.512 0.951 0.456
19. L3048LG274_2 kozakovvajda ligand_L0R_B_1.mol 0.802 2.512 0.951 0.456
20. L3048LG420_4 Zou_aff2 ligand_L0R_B_1.mol 0.798 1.700 0.885 0.538
21. L3048LG055_1 LCDD-team ligand_L0R_B_1.mol 0.798 2.571 0.922 0.518
22. L3048LG274_1 kozakovvajda ligand_L0R_B_1.mol 0.790 2.503 0.949 0.405
23. L3048LG494_1 ClusPro ligand_L0R_B_1.mol 0.790 2.503 0.949 0.405
24. L3048LG274_3 kozakovvajda ligand_L0R_B_1.mol 0.790 2.503 0.949 0.405
25. L3048LG494_3 ClusPro ligand_L0R_B_1.mol 0.790 2.503 0.949 0.405
26. L3048LG494_5 ClusPro ligand_L0R_B_1.mol 0.790 2.503 0.949 0.405
27. L3048LG274_5 kozakovvajda ligand_L0R_B_1.mol 0.790 2.503 0.949 0.405
28. L3048LG016_5 haiping ligand_L0R_B_1.mol 0.787 1.992 0.946 0.343
29. L3048LG091_1 Huang-HUST ligand_L0R_B_1.mol 0.785 2.548 0.920 0.485
30. L3048LG091_3 Huang-HUST ligand_L0R_B_1.mol 0.784 2.422 0.904 0.453
31. L3048LG082_1 VnsDock ligand_L0R_B_1.mol 0.776 2.054 0.948 0.347
32. L3048LG408_4 SNU-CHEM-lig ligand_L0R_B_1.mol 0.775 2.545 0.918 0.511
33. L3048LG008_1 HADDOCK ligand_L0R_B_1.mol 0.774 2.367 0.901 0.539
34. L3048LG207_3 MULTICOM_ligand ligand_L0R_B_1.mol 0.770 1.932 0.938 0.363
35. L3048LG207_4 MULTICOM_ligand ligand_L0R_B_1.mol 0.769 2.414 0.872 0.393
36. L3048LG207_2 MULTICOM_ligand ligand_L0R_B_1.mol 0.764 1.998 0.938 0.363
37. L3048LG408_1 SNU-CHEM-lig ligand_L0R_B_1.mol 0.760 2.521 0.890 0.634
38. L3048LG008_4 HADDOCK ligand_L0R_B_1.mol 0.759 2.061 0.888 0.619
39. L3048LG204_2 Zou ligand_L0R_B_1.mol 0.756 2.039 0.946 0.361
40. L3048LG091_2 Huang-HUST ligand_L0R_B_1.mol 0.750 2.461 0.859 0.351
41. L3048LG008_5 HADDOCK ligand_L0R_B_1.mol 0.745 2.388 0.917 0.554
42. L3048LG262_5 CoDock ligand_L0R_B_1.mol 0.742 2.264 0.846 0.523
43. L3048LG262_4 CoDock ligand_L0R_B_1.mol 0.742 2.264 0.846 0.523
44. L3048LG262_3 CoDock ligand_L0R_B_1.mol 0.742 2.264 0.846 0.523
45. L3048LG262_1 CoDock ligand_L0R_B_1.mol 0.742 2.264 0.846 0.523
46. L3048LG008_2 HADDOCK ligand_L0R_B_1.mol 0.716 2.914 0.893 0.520
47. L3048LG055_5 LCDD-team ligand_L0R_B_1.mol 0.698 2.120 0.922 0.518
48. L3048LG008_3 HADDOCK ligand_L0R_B_1.mol 0.668 2.556 0.863 0.619
49. L3048LG091_5 Huang-HUST ligand_L0R_B_1.mol 0.668 3.116 0.931 0.196
50. L3048LG091_4 Huang-HUST ligand_L0R_B_1.mol 0.633 3.427 0.859 0.351
51. L3048LG016_2 haiping ligand_L0R_B_1.mol 0.579 2.824 0.946 0.343
52. L3048LG016_1 haiping ligand_L0R_B_1.mol 0.566 2.902 0.946 0.343
53. L3048LG227_5 KUMC ligand_L0R_B_1.mol 0.545 3.255 0.932 0.351
54. L3048LG167_2 OpenComplex ligand_L0R_B_1.mol 0.535 2.010 0.610 2.196
55. L3048LG207_5 MULTICOM_ligand ligand_L0R_B_1.mol 0.522 3.115 0.856 0.507
56. L3048LG191_3 Schneidman ligand_L0R_B_1.mol 0.500 2.277 0.623 1.828
57. L3048LG191_2 Schneidman ligand_L0R_B_1.mol 0.415 2.261 0.633 1.804
58. L3048LG191_1 Schneidman ligand_L0R_B_1.mol 0.410 2.690 0.633 1.804
59. L3048LG432_5 DIMAIO ligand_L0R_B_1.mol 0.402 5.212 0.881 0.537
60. L3048LG309_2 Koes ligand_L0R_B_1.mol 0.367 4.575 0.630 1.714
61. L3048LG432_4 DIMAIO ligand_L0R_B_1.mol 0.361 4.961 0.837 0.336
62. L3048LG167_4 OpenComplex ligand_L0R_B_1.mol 0.336 5.616 0.638 1.676
63. L3048LG309_1 Koes ligand_L0R_B_1.mol 0.316 5.065 0.630 1.714
64. L3048LG309_3 Koes ligand_L0R_B_1.mol 0.295 6.755 0.634 1.719
65. L3048LG309_4 Koes ligand_L0R_B_1.mol 0.269 7.749 0.626 1.743
66. L3048LG204_4 Zou ligand_L0R_B_1.mol 0.264 7.017 0.937 0.348
67. L3048LG386_4 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.247 7.775 0.941 0.393
68. L3048LG298_4 ShanghaiTech-human ligand_L0R_B_1.mol 0.247 7.775 0.941 0.393
69. L3048LG298_2 ShanghaiTech-human ligand_L0R_B_1.mol 0.244 7.273 0.941 0.393
70. L3048LG386_2 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.244 7.273 0.941 0.393
71. L3048LG298_5 ShanghaiTech-human ligand_L0R_B_1.mol 0.243 7.756 0.941 0.393
72. L3048LG386_5 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.243 7.756 0.941 0.393
73. L3048LG420_3 Zou_aff2 ligand_L0R_B_1.mol 0.237 6.761 0.749 0.813
74. L3048LG204_5 Zou ligand_L0R_B_1.mol 0.237 6.761 0.749 0.813
75. L3048LG386_1 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.237 7.146 0.929 0.405
76. L3048LG298_1 ShanghaiTech-human ligand_L0R_B_1.mol 0.237 7.146 0.929 0.405
77. L3048LG227_2 KUMC ligand_L0R_B_1.mol 0.235 9.449 0.932 0.346
78. L3048LG227_3 KUMC ligand_L0R_B_1.mol 0.234 9.488 0.932 0.346
79. L3048LG227_1 KUMC ligand_L0R_B_1.mol 0.229 9.618 0.932 0.346
80. L3048LG227_4 KUMC ligand_L0R_B_1.mol 0.225 9.635 0.932 0.346
81. L3048LG294_1 KiharaLab ligand_L0R_B_1.mol 0.220 7.160 0.956 0.335
82. L3048LG020_2 comppharmunibas ligand_L0R_B_1.mol 0.215 7.623 0.948 0.450
83. L3048LG164_3 McGuffin ligand_L0R_B_1.mol 0.208 8.465 0.634 1.664
84. L3048LG164_4 McGuffin ligand_L0R_B_1.mol 0.204 6.233 0.634 1.664
85. L3048LG167_1 OpenComplex ligand_L0R_B_1.mol 0.196 10.016 0.532 2.445
86. L3048LG167_3 OpenComplex ligand_L0R_B_1.mol 0.194 9.027 0.597 1.681
87. L3048LG450_5 OpenComplex_Server ligand_L0R_B_1.mol 0.186 10.341 0.903 0.601
88. L3048LG167_5 OpenComplex ligand_L0R_B_1.mol 0.180 8.646 0.619 1.291
89. L3048LG164_5 McGuffin ligand_L0R_B_1.mol 0.167 8.654 0.634 1.664
90. L3048LG201_1 Drugit ligand_L0R_B_1.mol 0.166 11.756 0.931 0.425
91. L3048LG464_1 PocketTracer ligand_L0R_B_1.mol 0.161 9.359 0.629 1.765
92. L3048LG164_1 McGuffin ligand_L0R_B_1.mol 0.155 8.586 0.634 1.664
93. L3048LG020_4 comppharmunibas ligand_L0R_B_1.mol 0.154 8.343 0.948 0.450
94. L3048LG016_4 haiping ligand_L0R_B_1.mol 0.151 9.553 0.946 0.343
95. L3048LG016_3 haiping ligand_L0R_B_1.mol 0.150 9.562 0.946 0.343
96. L3048LG201_2 Drugit ligand_L0R_B_1.mol 0.148 14.003 0.882 0.545
97. L3048LG298_3 ShanghaiTech-human ligand_L0R_B_1.mol 0.136 9.503 0.941 0.393
98. L3048LG386_3 ShanghaiTech-Ligand ligand_L0R_B_1.mol 0.136 9.503 0.941 0.393
99. L3048LG262_2 CoDock ligand_L0R_B_1.mol 0.124 11.859 0.846 0.523
100. L3048LG464_3 PocketTracer ligand_L0R_B_1.mol 0.120 11.482 0.629 1.765
101. L3048LG450_3 OpenComplex_Server ligand_L0R_B_1.mol 0.094 10.624 0.903 0.601
102. L3048LG450_1 OpenComplex_Server ligand_L0R_B_1.mol 0.082 11.155 0.903 0.601
103. L3048LG450_2 OpenComplex_Server ligand_L0R_B_1.mol 0.078 13.828 0.903 0.601
104. L3048LG450_4 OpenComplex_Server ligand_L0R_B_1.mol 0.072 11.294 0.903 0.601
105. L3048LG464_4 PocketTracer ligand_L0R_B_1.mol 0.043 11.907 0.629 1.765
106. L3048LG464_5 PocketTracer ligand_L0R_B_1.mol 0.013 15.939 0.629 1.765
107. L3048LG464_2 PocketTracer ligand_L0R_B_1.mol 0.006 16.108 0.629 1.765
108. L3048LG164_2 McGuffin ligand_L0R_B_1.mol 0.000 31.713 0.639 1.673
109. L3048LG201_3 Drugit ligand_L0R_B_1.mol 0.000 40.593 0.929 0.287
110. L3048LG201_4 Drugit ligand_L0R_B_1.mol 0.000 42.721 0.929 0.287
Protein Structure Prediction Center
Sponsored by the US National Institute of General Medical Sciences (NIH/NIGMS)
Please address any questions or queries to:
© 2007-2024, University of California, Davis
Terms of Use